Experience with the Roche COBAS Ampliscreen™ HIV-1 v1.5 test applied to source plasma donor screening

被引:0
|
作者
Gray, M
Masecar, B
Burde, S
Gierman, T
Pietrelli, L
Lamendola, M
机构
[1] Bayer Healthcare, Raleigh, NC USA
[2] Roche Mol Syst, Pleasanton, CA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:94A / 94A
页数:1
相关论文
共 50 条
  • [41] Total HIV-1 DNA detection and quantification in peripheral blood by COBAS®AmpliPrep/COBAS® TaqMan® HIV-1 Test, v2.0
    Surdo, Matteo
    Bertoli, Ada
    Colucci, Giuseppe
    Sarmati, Loredana
    Andreoni, Massimo
    Perno, Carlo Federico
    Ceccherini-Silberstein, Francesca
    Ciotti, Marco
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2016, 54 (02) : E57 - E59
  • [42] Evaluation of the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 Test and Identification of Rare Polymorphisms Potentially Affecting Assay Performance
    Pyne, Michael T.
    Brown, Katherine L.
    Hillyard, David R.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2010, 48 (08) : 2852 - 2858
  • [43] System validation study for COBAS Ampliscreen HBV, HCV and HIV-1 tests - PCR based assays for blood screening.
    Yang, Y
    Ohde, D
    Daneshmand, S
    Wu, Y
    Mendoza, M
    Wang, Y
    Yeh, S
    Gallarda, J
    TRANSFUSION, 2002, 42 (09) : 84S - 84S
  • [44] Comparative evaluation of the Cobas Amplicor HIV-1 Monitor™ ultrasensitive test, the new Cobas AmpliPrep/Cobas Amplicor HIV-1 Monitor™ ultrasensitive test and the versant HIV RNA 3.0 assays for quantitation of HIV-1 RNA in plasma samples
    Berger, A
    Scherzed, L
    Sturmer, M
    Preiser, W
    Doerr, HW
    Rabenau, HF
    JOURNAL OF CLINICAL VIROLOGY, 2005, 33 (01) : 43 - 51
  • [45] Evaluation of the Effect of Specimen Handling Conditions in BD Vacutainer® PPT on the Stability of HIV-1 Viral Load Using Roche COBAS® AmpliPrep/COBAS® TaqMan® HIV-1 Test
    Fernandes, H.
    Ramanathan, M.
    Morosyuk, S.
    Rose, S.
    Rainen, L.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2009, 11 (06): : 640 - 640
  • [46] Classification of HIV-1 virological treatment failure using the Roche cobas plasma separation card on cobas 8800 compared to dried blood spots on Abbott RealTime HIV-1
    Hans, Lucia
    Marins, Ed G.
    Simon, Christian O.
    Magubane, Dieketseng
    Seiverth, Britta
    Carmona, Sergio
    JOURNAL OF CLINICAL VIROLOGY, 2021, 140
  • [47] Comparative evaluation of the Aptima HIV-1 Quant Dx assay and COBAS TaqMan HIV-1 v2.0 assay using the Roche High Pure System for the quantification of HIV-1 RNA in plasma
    Schalasta, Gunnar
    Boerner, Anna
    Speicher, Andrea
    Enders, Martin
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2016, 54 (03) : 493 - 499
  • [48] Successful use of Plasma Preparation Tubes™ (PPTs) in the COBAS® AmpliPrep/COBAS® TaqMan® HIV-1 Test
    Kraft, Colleen S.
    Binongo, Jose Nilo G.
    Burd, Eileen M.
    Eaton, Molly E.
    McCloskey, Cindy B.
    Fernandes, Helen
    Hill, Charles E.
    Caliendo, Angela M.
    JOURNAL OF CLINICAL VIROLOGY, 2013, 57 (01) : 77 - 79
  • [49] Comparison of the Aptima HIV-1 Quant Dx assay with the COBAS AmpliPrep/COBAS TaqMan HIV-1 v2.0 Test for HIV-1 viral load quantification in plasma samples from HIV-1-infected patients
    Longo, Serena
    Bon, Isabella
    Musumeci, Giuseppina
    Bertoldi, Alessia
    D'Urbano, Vanessa
    Calza, Leonardo
    Re, Maria Carla
    HEALTH SCIENCE REPORTS, 2018, 1 (04)
  • [50] Comparing Abbott m2000 RealTime HIV test and Roche COBAS Ampliprep/COBAS Taqman HIV test, v2.0 in treated HIV-1 B and non-B subjects with low viraemia
    Margariti, Apostolia
    Chatzidimitriou, Dimitrios
    Metallidis, Simeon
    Pilalas, Dimitrios
    Kourelis, Andreas
    Papadimitriou, Evangelia
    Haidich, Anna-Bettina
    Malisiovas, Nicolaos
    Skoura, Lemonia
    JOURNAL OF MEDICAL VIROLOGY, 2016, 88 (04) : 724 - 727